Advisory on Exclusivity Claims for Indications

[admin]

Expanding the approach to exclusivity claims

@Agency and @Manufacturer A new advisory has been posted on Exclusivity Claims for Indications. If you have any questions, please post below:

[NatBourre]

@admin Thank you for this advisory.

1. Does the font for the indication of product B need to be the same size as the font of product A?

2. If an APS mentions product A by brand name, is it acceptable to refer to product B by its generic name?

[Jennifer Carroll]

Hello @natbourre

1. No, but the indication size should be proportional to the claim size
2. Yes, it is acceptable to use the generic name.